Position in NVS
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$1,111,458
+$28,155 QoQ
Shares Held
7,092
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#589
of 1,603 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026St. Clair Advisors, LLC holds $10,019,901 across 6 Drug Manufacturers - General names. NVS ranks #2 (11.1% of the industry book) .
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,111,458 | 7,092 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $1,083,303 | 7,092 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $977,774 | 7,092 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $909,478 | 7,092 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $858,202 | 7,092 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $790,616 | 7,092 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $690,122 | 7,092 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $815,721 | 7,092 | Shares | Sole | 2025-04-10 | |
| 2024-06-30 | $755,014 | 7,092 | Shares | Sole | 2025-04-10 | |
| 2024-03-31 | $686,009 | 7,092 | Shares | Sole | 2025-04-10 | |
| 2023-12-31 | $716,079 | 7,092 | Shares | Sole | 2025-04-10 | |
| 2023-09-30 | $722,391 | 7,092 | Shares | Sole | 2025-04-10 | |
| 2023-06-30 | $715,653 | 7,092 | Shares | Sole | 2025-04-10 | |
| 2023-03-31 | $569,572 | 6,191 | Shares | Sole | 2025-04-10 | |
| No filing history on record for this holder in this stock. | ||||||